Ind-Swift Laboratories Limited
NSE:INDSWFTLAB.NS
Overview | Financials
Company Name | Ind-Swift Laboratories Limited |
Symbol | INDSWFTLAB.NS |
Currency | INR |
Price | 117.51 |
Market Cap | 6,943,301,619 |
Dividend Yield | 0% |
52-week-range | 89.05 - 186 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Navrattan Munjal |
Website | https://www.indswiftlabs.com |
An error occurred while fetching data.
About Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD